85 related articles for article (PubMed ID: 21972143)
1. Analysis of HDAC1-mediated regulation of Runx2-induced osteopontin gene expression in C3h10t1/2 cells.
Zhang Z; Deepak V; Meng L; Wang L; Li Y; Jiang Q; Zeng X; Liu W
Biotechnol Lett; 2012 Feb; 34(2):197-203. PubMed ID: 21972143
[TBL] [Abstract][Full Text] [Related]
2. Reduced activity and cytoplasmic localization of Runx2 is observed in C3h10t1/2 cells overexpressing Tbx3.
Deepak V; Zhang Z; Meng L; Zeng X; Liu W
Cell Biochem Funct; 2011 Jun; 29(4):348-50. PubMed ID: 21455926
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
4. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26.
Mikami Y; Takahashi T; Kato S; Takagi M
Cell Biol Int; 2008 Feb; 32(2):239-46. PubMed ID: 17950631
[TBL] [Abstract][Full Text] [Related]
6. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A activates the osteopontin gene promoter through AP1 site.
Sakata R; Minami S; Sowa Y; Yoshida M; Tamaki T
Biochem Biophys Res Commun; 2004 Mar; 315(4):959-63. PubMed ID: 14985105
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells.
Nakahara T; Sato H; Shimizu T; Tanaka T; Matsui H; Kawai-Kowase K; Sato M; Iso T; Arai M; Kurabayashi M
Biochem Biophys Res Commun; 2010 Apr; 394(2):243-8. PubMed ID: 19903460
[TBL] [Abstract][Full Text] [Related]
9. Nkx3.2-induced suppression of Runx2 is a crucial mediator of hypoxia-dependent maintenance of chondrocyte phenotypes.
Kawato Y; Hirao M; Ebina K; Tamai N; Shi K; Hashimoto J; Yoshikawa H; Myoui A
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):205-10. PubMed ID: 22093831
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator.
Tamiya H; Ikeda T; Jeong JH; Saito T; Yano F; Jung YK; Ohba S; Kawaguchi H; Chung UI; Choi JY
Gene; 2008 Jun; 416(1-2):53-60. PubMed ID: 18442887
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
13. A RUNX2-HDAC1 co-repressor complex regulates rRNA gene expression by modulating UBF acetylation.
Ali SA; Dobson JR; Lian JB; Stein JL; van Wijnen AJ; Zaidi SK; Stein GS
J Cell Sci; 2012 Jun; 125(Pt 11):2732-9. PubMed ID: 22393235
[TBL] [Abstract][Full Text] [Related]
14. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
[TBL] [Abstract][Full Text] [Related]
15. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK.
Lee HW; Suh JH; Kim HN; Kim AY; Park SY; Shin CS; Choi JY; Kim JB
J Bone Miner Res; 2008 Aug; 23(8):1227-37. PubMed ID: 18410224
[TBL] [Abstract][Full Text] [Related]
16. Expression of RUNX2 isoforms: involvement of cap-dependent and cap-independent mechanisms of translation.
Elango N; Li Y; Shivshankar P; Katz MS
J Cell Biochem; 2006 Nov; 99(4):1108-21. PubMed ID: 16767703
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.
Shen Q; Christakos S
J Biol Chem; 2005 Dec; 280(49):40589-98. PubMed ID: 16195230
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional co-repressors of Runx2.
Westendorf JJ
J Cell Biochem; 2006 May; 98(1):54-64. PubMed ID: 16440320
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.
Yang X; Meng X; Su X; Mauchley DC; Ao L; Cleveland JC; Fullerton DA
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):1008-15. PubMed ID: 19664780
[TBL] [Abstract][Full Text] [Related]
20. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
